Skip to main content

Table 4 Quality of life in breast cancer patients before and after intervention in KD group and control group as measured by the EORTC QLQBR23a

From: Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial

 

KD

Control

p-value

aFunctioning

 Future perspective

  Week 0

66 (33–100)

66 (33–66)

0/60

  Week 12

66 (33–66)

33 (33–100)

0/85

  p-value

0/45

0/76

 

bSymptoms+

 Arm

  Week 0

11 (0–36)

11 (0–22)

0/36

  Week 12

11 (0–36)

22 (0–33)

88

  p-value

0/70

0/59

 

 Breast

  Week 0

8 (0–33)

8 (0–25)

0/34

  Week 12

8 (0–10)

8 (0–16)

0/55

  p-value

0/01

0/34

 

 Systemic therapy side effects

  Week 0

9 (4–17)

14 (4–23)

0/54

  Week 12

42 (20–52)

42 (33–52)

0/33

  p-value

0</001

0</001

 

 Concerns over hair loss

  Week 0

0

0

0/20

  Week 12

66 (33–100)

33 (33–100)

0/50

  p-value

0</001

0</001

 
  1. Mann–Whitney U test was used to compare the continuous variables between the two groups. Wilcoxon was used to compare the continuous variables within the two groups
  2. aThe higher values indicate higher level of functioning and quality of life
  3. bThe higher values indicate a higher grade of symptoms
  4. Data shown as median and quartile (25, 75)